Blue or green dye eye surgery to help remove retinal tissue
Part of Eyes & vision clinical trials.
This trial studies an eye surgery technique that uses a colored dye (blue or green) to help the surgeon carefully remove a thin inner retinal layer. It may help make the procedure more precise and safer, and the study compares how the dye-assisted method works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have not had any dye-assisted “chromovitrectomy” surgery in the last 6 months
- In your surgery, the plan is to use only one dye from the following: Brilliant Blue (BBG), Indocyanine Green (ICG), or (not both) Trypan Blue (TB)
- Do not be pregnant at the time of the surgery
- Have no other chromovitrectomy in the last 6 months (this includes any prior similar surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This trial tests an experimental medication (BI 1815368) given as an eye injection for people with diabetic macular edema, a condition where fluid builds up in the center of the retina and blurs vision. The study aims to see if this new treatment can reduce swelling and improve vision.
This trial tests whether specially trained nurses can safely give eye injections instead of doctors. It may make treatment quicker and easier for people who need regular injections for eye conditions.
This trial tests whether a specific eye surgery plus targeted clot-busting medicine and gas can improve vision after bleeding under the retina from “wet” age-related macular degeneration. It aims to reduce how long the bleeding lasts and help protect the central vision.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
This trial compares a minimally invasive eye procedure (vitrectomy with peeling) versus anti-VEGF injections to treat new diabetic macular edema in people who have not had treatment yet. It looks at which option improves vision and eye swelling for people with diabetes.
Hear when a new Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.